TITLE
Acute myeloblastic leukemia cells response to all trans retinoic acid and valproic acid

SUMMARY
Analysis of acute myeloblastic leukemia (AML) cell line, OCI/AML-2, following treatment with valproic acid (VPA) and all trans retinoic acid (ATRA). VPA inhibits histone deacetylase. Results provide insight into the responsiveness of AML cells to ATRA when VPA is present.

ORGANISM
Homo sapiens

PLATFORM
GPL96 : [HG-U133A] Affymetrix Human Genome U133A Array

CITATIONS
Trus MR, Yang L, Suarez Saiz F, Bordeleau L et al. The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells. Leukemia 2005 Jul;19(7):1161-8. PMID:Â  15902297

